| Basics |
Edwards Lifesciences Corp
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
|
| IPO Date: |
April 3, 2000 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$43.88B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.98 | 1.07%
|
| Avg Daily Range (30 D): |
$0.97 | 1.35%
|
| Avg Daily Range (90 D): |
$0.72 | 1.01%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.35M |
| Avg Daily Volume (30 D): |
4.12M |
| Avg Daily Volume (90 D): |
3.67M |
| Trade Size |
| Avg Trade Size (Sh.): |
92 |
| Avg Trade Size (Sh.) (30 D): |
73 |
| Avg Trade Size (Sh.) (90 D): |
73 |
| Institutional Trades |
| Total Inst.Trades: |
26,259 |
| Avg Inst. Trade: |
$5.95M |
| Avg Inst. Trade (30 D): |
$7.73M |
| Avg Inst. Trade (90 D): |
$8.08M |
| Avg Inst. Trade Volume: |
.16M |
| Avg Inst. Trades (Per Day): |
5 |
| Market Closing Trades |
| Avg Closing Trade: |
$20.42M |
| Avg Closing Trade (30 D): |
$46.71M |
| Avg Closing Trade (90 D): |
$52.75M |
| Avg Closing Volume: |
392.05K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q3 2024 |
|
Basic EPS
|
|
$.61
|
$5.14
|
|
Diluted EPS
|
|
$.61
|
$5.13
|
|
Revenue
|
$
|
$ 1.41B
|
$ 1.35B
|
|
Gross Profit
|
$
|
$ 1.11B
|
$ 1.09B
|
|
Net Income / Loss
|
$
|
$ 356.4M
|
$ 3.07B
|
|
Operating Income / Loss
|
$
|
$ 394.8M
|
$ 350.6M
|
|
Cost of Revenue
|
$
|
$ 301.6M
|
$ 262.9M
|
|
Net Cash Flow
|
$
|
$ 90M
|
$ 2.03B
|
|
PE Ratio
|
|
|
|
| Splits |
| Jun 01, 2020:
1:3
|
| Dec 14, 2015:
1:2
|
| May 28, 2010:
1:2
|
|
